Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease

Movement Disorders - United States
doi 10.1002/mds.27993
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Wiley

Related search

A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Aromatic L-Amino Acid Decarboxylase Deficiency

2020English

Distribution of Aromatic L-Amino Acid Decarboxylase Activity in Tissues of Skipjack

Fisheries Science
Aquatic Science
1995English

Levodopa Response After Unilateral Pallidotomy in Advanced Parkinson's Disease

Journal of Korean Society for Clinical Pharmacology and Therapeutics
2001English

Urine Organic Acid (UOA) Analysis for the Diagnosis of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency

Pathology
Forensic MedicinePathology
2020English

Aromatic Amino Acid Hydroxylases and Mental Disease

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1980English

Levodopa Dosage and Ventilatory Function in Parkinson's Disease.

BMJ
1981English

Response of Non-Motor Symptoms to Levodopa in Late-Stage Parkinson's Disease: Results of a Levodopa Challenge Test

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2017English

Levodopa-Induced Dyskinesia in Parkinson's Disease: Sleep Matters

Annals of Neurology
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy